June 14, 2022
Category :Diabetes Research
0
A newer and longer-acting form of the diabetes drug exenatide (Byetta) taken once a week did better at controlling blood glucose levels compared to its standard formula, according to a new study published recently in the journal, The Lancet.
» Continue Reading
Related terms:
blood glucose levels, Byetta, diabetes drug, glucose control, low blood sugar, promising treatment, type 2 diabetes
July 27, 2021
Category :Healthy News
0
EIi Lilly and Company and Amylin Pharmaceuticals, Inc. recently announced that the European Commission has granted marketing authorization for Byetta (exenatide) for the treatment of type 2 diabetes. Exenatide is now approved in the European Union as adjunctive therapy to improve blood sugar control in patients with type 2 diabetes who have not achieved adequate glycemic control on maximally tolerated doses of metformin and/or a sulfonylurea, two common oral diabetes medications. Exenatide is the first in a new class of antidiabetic medicines known as incretin mimetics.
» Continue Reading
Byetta, exenatide, type 2 diabetes
December 23, 2020
Category :Healthy News
0
The use of insulin pens is fast becoming a norm among diabetic patients for its convenience. Insulin pen offers portability which means it can be carried easily anywhere and conveniently be injected anywhere and anytime. It extinguishes the fear of using needles especially among children. Insulin pen allows diabetics to administer insulin discretely. It has a longer shelf life and more importantly, it allows for administering accurate dosage of insulin.
» Continue Reading
Byetta, diabetic patients, insulin glargine, insulin pens